| GENZOR, Samuel, Pavol POBEHA, Martin SIMEK, Petr JAKUBEC, Jan MIZERA, Martin VYKOPAL, Milan SOVA, Jakub VANEK a Jan PRASKO. Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19. LIFE-BASEL. BASEL: MDPI, 2023, roč. 13, č. 4, s. 1-11. ISSN 2075-1729. Dostupné z: https://dx.doi.org/10.3390/life13041054. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2296999,
author = {Genzor, Samuel and Pobeha, Pavol and Simek, Martin and Jakubec, Petr and Mizera, Jan and Vykopal, Martin and Sova, Milan and Vanek, Jakub and Prasko, Jan},
article_location = {BASEL},
article_number = {4},
doi = {http://dx.doi.org/10.3390/life13041054},
keywords = {ECMO; COVID-19; long-term outcome},
language = {eng},
issn = {2075-1729},
journal = {LIFE-BASEL},
title = {Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19},
url = {https://www.mdpi.com/2075-1729/13/4/1054},
volume = {13},
year = {2023}
}
TY - JOUR
ID - 2296999
AU - Genzor, Samuel - Pobeha, Pavol - Simek, Martin - Jakubec, Petr - Mizera, Jan - Vykopal, Martin - Sova, Milan - Vanek, Jakub - Prasko, Jan
PY - 2023
TI - Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19
JF - LIFE-BASEL
VL - 13
IS - 4
SP - 1-11
EP - 1-11
PB - MDPI
SN - 20751729
KW - ECMO
KW - COVID-19
KW - long-term outcome
UR - https://www.mdpi.com/2075-1729/13/4/1054
N2 - Introduction: Severe respiratory failure is one of the most serious complications of coronavirus disease 2019 (COVID-19). In a small proportion of patients, mechanical ventilation fails to provide adequate oxygenation and extracorporeal membrane oxygenation (ECMO) is needed. The surviving individuals need long-term follow-up as it is not clear what their prognosis is. Aim: To provide a complex clinical picture of patients during follow-up exceeding one year after the ECMO therapy due to severe COVID-19. Methods: All subjects involved in the study required ECMO in the acute stage of COVID-19. The survivors were followed-up for over one year at a specialized respiratory medical center. Results: Of the 41 patients indicated for ECMO, 17 patients (64.7% males) survived. The average age of survivors was 47.8 years, and the average BMI was 34.7 kg center dot m(-2). The duration of ECMO support was 9.4 days. A mild decrease in vital capacity (VC) and transfer factor (DLCO) was observed on the initial follow-up visit (82.1% and 60%, respectively). VC improved by 6.2% and by an additional 7.5% after 6 months and 1 year, respectively. DLCO improved by 21.1% after 6 months and remained stable after 1 year. Post-intensive care consequences included psychological problems and neurological impairment in 29% of patients; 64.7% of the survivors got vaccinated against SARS-CoV-2 within 12 months of hospitalization and 17.6% experienced reinfection with a mild course. Conclusion: The COVID-19 pandemic has significantly increased the need for ECMO. Patients' quality of life after ECMO is temporarily significantly reduced but most patients do not experience permanent disability.
ER -
GENZOR, Samuel, Pavol POBEHA, Martin SIMEK, Petr JAKUBEC, Jan MIZERA, Martin VYKOPAL, Milan SOVA, Jakub VANEK a Jan PRASKO. Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19. \textit{LIFE-BASEL}. BASEL: MDPI, 2023, roč.~13, č.~4, s.~1-11. ISSN~2075-1729. Dostupné z: https://dx.doi.org/10.3390/life13041054.
|
